Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) is associated with advanced stage and invasiveness of gastric carcinomas

Japanese Journal of Cancer Research

Volumn 88, Issue 7, 1997, Pages 625-629

  Yasui, Wataru ^a   Kudo, Yasusei ^a   Semba, Shuho ^a   Yokozaki, Hiroshi ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CDK inhibitor; Gastric carcinoma; Immunohistochemistry; Northern blotting; p27(Kip1)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E;

ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER INVASION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 0030855876     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00428.x     Document Type: Article

References (20)

1. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79, 515-555 (1994).
2. Hunter, T. and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
3. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T. and Tahara, E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86, 617-621 (1995).
4. Yasui, W., Akama, Y., Kuniyasu, H., Yokozaki, H., Shimamoto, F. and Tahara, E. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J. Exp. Ther. Oncol., 1, 88-94 (1996).
5. Harper, J. W., Adami, G, R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
6. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Gene Dev., 8, 9-22 (1994).
7. Kip1, a cyclin-dependent kinase and a potent mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994).
8. Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
9. Nobori T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756 (1994).
10. Serrano, M., Hannon, G. J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707 (1993).
11. Kip1 in a human gastric carcinoma cell line. Cell Growth Differ., 8, 47-52 (1997).
12. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55, 1211-1214 (1995).
13. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartram, C. R. and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269 (1995).
14. Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat. Med., 2, 222-225 (1997).
15. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 2, 227-230 (1997).
16. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M. and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 2, 231-234 (1997).
17. Japanese Research Society for Gastric Cancer. "Japanese Classification of Gastric Carcinoma," 1st English ed. (1995). Kanehara Co., Tokyo.
18. Yasui, W., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F. and Tahara, E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 and p53 protein. Virchows Arch., 429, 13-19 (1996).
19. Kip1 accumulation during the cell cycle. Science, 271, 1861-1864 (1996).
20. WAF1/CIP1 in nonneoplastic mucosa and neoplasia of the stomach: relation with p53 status and proliferative activity. J. Pathol., 180, 122-128 (1996).